Carterra Inc.

Carterra® is the leading provider of high throughput technologies designed to accelerate and improve the discovery of novel therapeutic candidates.

Articles by Carterra Inc.

Carterra® Announces Successful Immunity Monitoring of COVID-19 Patients Using a SARS-CoV-2 Label-Free Assay

Aug 24, 2020|2 min read

byCarterra Inc.

A new SARS-CoV-2 spike protein biosensor chip was successfully deployed for simultaneous measurements of IgG, IgA, and IgM using only 2 µl of serum per patient

Carterra® Inc. Selected by the La Jolla Institute of Immunology to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)

Mar 31, 2020|3 min read

byCarterra Inc.

Funded by the Bill and Melinda Gates Foundation, CoVIC seeks to find therapeutic candidates for COVID-19 in just weeks